Visa has moved its stablecoin-enabled prefunding for Visa Direct from pilot to commercial production, allowing payment providers on Inyo Global's platform to fund cross-border payouts using USDC anytime. This removes traditional banking cutoffs, enabling near real-time prefunding 24/7 through existing APIs without system rebuilds. The integration improves liquidity management for money transmitters and fintechs, offering a new funding option alongside Mastercard Send and local banks. Inyo also manages compliance across jurisdictions via its InyoX entity, addressing regulatory challenges for stablecoin use globally.
Visa Direct's USDC prefunding launch provides context for cryptocurrency market activity. For readers following crypto assets, here is Pluang's market snapshot as of Oct 15, 2026 22:22 WIB: out of 50 major cryptocurrencies priced on Pluang, 20 rose and 29 fell today. Notable movers include MANA at Rp1.545 with a 1-day change of -4.45%, SNX at Rp3.951 down 4.38%, and AXS at Rp18.672 down 4.36%.
Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant...
CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...
At the 13th annual Muhammad Ali Humanitarian Awards in Louisville, Colin Kaepernick was honored as Humanitarian of the Year for his activism and entrepreneurship, including founding literacy platform Lumi and Know Your Rights Camp. The event also rec...
Cabaletta Bio announced Phase 1/2 clinical data for rese-cel, a CAR T cell therapy targeting autoimmune diseases, showing durable benefits without immunomodulators across dermatomyositis, lupus nephritis, and systemic sclerosis patients. All dermatom...
Anthropic's anticipated IPO valuation has potentially dropped from $2.5 trillion to around $1 trillion amid a tech selloff and investor pushback. Despite strong revenue growth, the company faces massive future spending commitments and slower growth, ...
